By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina this week said that Macrogen, a Korea-based sequencing services firm, has purchased an additional 10 HiSeq 2000 systems and two MiSeq systems, in addition to upgrades for its HiSeq 2500. Macrogen also intends to develop diagnostic tests based on the MiSeq platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.